Booster Therapeutics to develop proteasome activator medicines
Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for neurodegenerative diseases.
Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for neurodegenerative diseases.
What's Your Reaction?
